Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
| |||
| December 31, 2022 |
| January 1,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 499,915 |
| $1,074,623 |
Short-term investments | 692,024 |
| 964,582 |
Accounts receivable, net | 71,437 |
| 98,313 |
Inventories | 100,417 |
| 49,307 |
Prepaid expenses and other current assets | 97,570 |
| 51,748 |
Total current assets | 1,461,363 |
| 2,238,573 |
Property and equipment, net | 152,016 |
| 146,516 |
Goodwill | 376,389 |
| 376,389 |
Other intangible assets, net | 84,907 |
| 118,978 |
Other assets, net | 94,753 |
| 77,839 |
Total assets | $2,169,428 |
| $2,958,295 |
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 89,860 |
| $ 47,327 |
Current portion of convertible debt, net | -- |
| 450,599 |
Deferred revenue and returns liability | 6,780 |
| 13,849 |
Other current liabilities | 89,136 |
| 157,052 |
Total current liabilities | 185,776 |
| 668,827 |
Convertible debt, net | 529,573 |
| -- |
Other non-current liabilities | 49,071 |
| 77,044 |
Total liabilities | 764,420 |
| 745,871 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
Common stock – $0.0001 par value; 250,000 shares authorized; 31,994 and 38,481 shares issued and outstanding at December 31, 2022 and January 1, 2022, respectively | 3 |
| 4 |
Retained earnings | 1,415,693 |
| 2,214,839 |
Accumulated other comprehensive loss | (10,688) |
| (2,419) |
Total stockholders' equity | 1,405,008 |
| 2,212,424 |
Total liabilities and stockholders' equity | $2,169,428 |
| $2,958,295 |